project id: TCGA-STAD; case submitter id: TCGA-VQ-AA6D; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 8.8; age at index: 52; days to birth: -19090; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1961; age at diagnosis: 19090; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 521.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8211/3; primary diagnosis: Tubular adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 294; days to sample procurement: 0; initial weight: 100.0; portion submitter id: TCGA-VQ-AA6D-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 98.0; percent tumor nuclei: 70.0;